This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Henan Zhiwei Biomedicine Co., Ltd., Henan Zhiwei Biomedicine Co., Ltd.. Active years: 2025-2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025-2026
Title: Shouning Yang: Innovator in Biomedicine
Introduction
Shouning Yang is a prominent inventor based in Xinxiang, China. He has made significant contributions to the field of biomedicine, particularly in the development of compounds that target Bruton's Tyrosine Kinase (BTK). With a total of 2 patents, his work is paving the way for new treatments for various diseases.
Latest Patents
Yang's latest patents include innovative compounds aimed at treating autoimmune diseases, inflammatory diseases, cancer, and potentially allergies. The first patent, titled "Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitors," discloses a series of substituted imidazolecarboxamide compounds that serve as BTK inhibitors. The second patent, "Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors," presents a compound or its pharmaceutically acceptable variants that also function as BTK inhibitors.
Career Highlights
Throughout his career, Shouning Yang has worked with Henan Zhiwei Biomedicine Co., Ltd., where he has contributed to the advancement of biomedicine through his innovative research and development efforts. His work has been instrumental in exploring new therapeutic avenues for complex diseases.
Collaborations
Yang has collaborated with notable colleagues, including Yuqin Jiang and Guiqing Xu, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Shouning Yang's contributions to biomedicine through his patents and collaborations highlight his role as an innovator in the field. His work continues to inspire advancements in the treatment of serious health conditions.